Rohto Pharmaceutical Co.,Ltd.
4527
Kedudukan dalam Saham
#3839
Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global... Established in Osaka, Japan, in 1899, Rohto Pharmaceutical Co.,Ltd. is a global entity engaged in the development, manufacturing, and marketing of a diverse array of pharmaceutical goods, beauty products, and nutritional supplements. Their comprehensive product line includes various ophthalmic solutions such as eye drops, contact lens care products, and eye washes. For skincare, they offer facial treatments like cleansers, toners, and creams, in addition to specialized medicated preparations for the skin. The company's offerings also extend to internal medicines, encompassing digestive aids, herbal remedies, and dietary supplements. Furthermore, they supply over-the-counter medications and deliver beauty and health services via dedicated counters. The company rebranded from Yamada Pharmaceutical to Rohto Pharmaceutical Co.,Ltd. in September 1949.
Harga Saham
$19.13
Modal Pasaran
$4.32B
Perubahan (1 hari)
0.64%
Perubahan (1 tahun)
16.90%
Negara
JP
Perdagangan Rohto Pharmaceutical Co.,Ltd. (4527)
Kategori
Consumer Defensive
Hasil untuk Rohto Pharmaceutical Co.,Ltd. (4527)
Hasil pada Jun 2026 TTM: $2.31B
Menurut laporan kewangan terkini daripada Rohto Pharmaceutical Co.,Ltd., hasil semasa syarikat (TTM) ialah $2.31B. Pada tahun 2024, syarikat memperoleh hasil sebanyak $1.79B penurunan berbanding hasil pada tahun 2023 iaitu $1.80B. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Rohto Pharmaceutical Co.,Ltd. dari 2008 hingga 2026
Hasil pada akhir setiap tahun
| Tahun | Hasil | Ubah |
|---|---|---|
| 2026 (TTM) | $2.31B | 11.98% |
| 2025 | $2.06B | 15.06% |
| 2024 | $1.79B | -0.45% |
| 2023 | $1.80B | 9.63% |
| 2022 | $1.64B | 0.31% |
| 2021 | $1.63B | -6.70% |
| 2020 | $1.75B | 5.89% |
| 2019 | $1.65B | 2.34% |
| 2018 | $1.62B | 16.49% |
| 2017 | $1.39B | -6.19% |
| 2016 | $1.48B | 16.76% |
| 2015 | $1.27B | -9.28% |
| 2014 | $1.40B | 2.31% |
| 2013 | $1.37B | -5.93% |
| 2012 | $1.45B | 4.39% |
| 2011 | $1.39B | 14.55% |
| 2010 | $1.21B | 8.00% |
| 2009 | $1.12B | 3.58% |
| 2008 | $1.09B | 0.00% |
Hasil untuk syarikat atau pesaing serupa
| Syarikat | Hasil | Perbezaan Hasil | Negara |
|---|---|---|---|
| $87.03B | 3,674.79% |
US
|
|
| $51.67B | 2,140.87% |
FR
|
|
| $21.05B | 812.82% |
US
|
|
| $7.28B | 215.96% |
IN
|
|
| $15.05B | 552.71% |
US
|
